Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIronveld Regulatory News (IRON)

Share Price Information for Ironveld (IRON)

Share Price is delayed by 15 minutes
Get Live Data
0.0205    0.00 (0.00%)
Bid:
0.02
Ask:
0.021
Spread: 0.001 (5.00%)
Market Cap: £4.25m
IRON Live PriceLast checked at - London Stock Exchange

Intraday Ironveld Share Chart

Board Appointment

2 Nov 2022 07:00

RNS Number : 9779E
Ironveld PLC
02 November 2022
 

Ironveld Plc

("Ironveld" or the "Company")

Board Appointment

Ironveld (AIM:IRON) is pleased to announce the appointment of Dr John Wardle as a Non-Executive Director of the Company, with immediate effect.

 

John, whose first degree was in Mining Engineering followed by a PhD in Microseismic Geotechnics, was most recently CEO of Amerisur Resources Plc, the AIM-listed Oil & Gas company, from 2007 to 2020 when it was acquired for approximately £242 million. Prior to this John held roles with BP, Britoil, Emerald Energy and Pebercan.

 

John is the 100% beneficial owner of Tracarta Limited, which holds 237,046,901 ordinary shares in Ironveld representing 8.19 per cent. of the Company's issued share capital.

 

John will also become a member of Ironveld's Audit and Remuneration Committees.

 

Commenting, Ironveld Chairman Giles Clarke, said

 

"I am delighted to welcome John to the Board at this critical and exciting time in Ironveld's development. As well as being a supportive shareholder in the Company, John and I worked together successfully for many years at Amerisur and I know that he brings an impressive range of skills and experience to support the Executive team as we make the transition into production."

 

Regulatory disclosures

The following information is disclosed pursuant to Rule 17 and Schedule Two paragraph (g) of the AIM Rules for Companies in relation to Dr John Wardle, aged 63:

Current Directorships

None

Directorships within the past 5 years:

Amerisur Resources plc

Ironveld confirms that there are no other disclosures to be made pursuant to Rule 17 and Schedule Two paragraph (g) of the AIM Rules for Companies with respect to Dr John Wardle.

 

For further information, please contact:

Ironveld plc

Martin Eales, Chief Executive Officer

c/o BlytheRay

020 7138 3204

 

 

finnCap (Nomad and Broker)

Christopher Raggett

Charlie Beeson

 

 

020 7220 0500

 

 

Turner Pope (Joint Broker)

Andy Thacker

James Pope

 

 

020 3657 0050

BlytheRay

Megan Ray

Tim Blythe

 

020 7138 3204

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAEAKFFESNAFFA
Date   Source Headline
3rd Sep 20207:00 amRNSFurther Extension of IIG Option Agreement
18th Aug 20202:53 pmRNSChange of Registered Office address
11th Jun 20207:00 amRNSBridge Loan Facility and Extension of IIG Option
27th May 20207:00 amRNSUpdate on IIG Option Agreement
23rd Apr 20208:09 amRNSBlocklisting Return
30th Mar 202010:30 amRNSInterim results
30th Mar 202010:00 amRNSStrategic Partnership and Conditional Fundraising
4th Feb 20209:21 amRNSNotification of Transaction
3rd Feb 20207:00 amRNSLoan Facilities Agreement
10th Jan 202012:45 pmRNSGrant of Share Options
10th Jan 202010:20 amRNSResult of AGM
24th Dec 20197:00 amRNSPublication of Annual Report and Notice of AGM
6th Dec 20197:00 amRNSAppointment of Chief Executive Officer ("CEO")
5th Dec 20197:00 amRNSFinal results for the year ended 30 June 2019
22nd Oct 20197:00 amRNSBlocklisting Return
30th Sep 20197:00 amRNSUpdate on Strategic Review
24th Sep 20197:00 amRNSDirectorate Change
19th Sep 20197:00 amRNSDirectorate Change
12th Aug 20197:00 amRNSUpdate on Strategic Review
16th Jul 20198:00 amRNSPublication of Research
2nd Jul 20197:00 amRNSStrategic Review
5th Jun 20197:00 amRNSUpdate on off-take discussions
23rd Apr 20197:00 amRNSBlocklisting Return
28th Mar 20197:00 amRNSInterim results for the 6 months ended 31 Dec 2018
19th Feb 20197:00 amRNSPlacing to raise £1.1 million
14th Feb 20197:00 amRNSUpdate on bulk sampling programme
18th Jan 201911:30 amRNSResult of AGM
18th Jan 20197:00 amRNSCompany Update
21st Dec 201810:25 amRNSNotice of AGM
7th Dec 20187:00 amRNSFinal results for the year ended 30 June 2018
19th Nov 20187:00 amRNSPlacing to raise £400,000
7th Nov 20182:15 pmRNSNotification of major holdings
22nd Oct 20187:00 amRNSBlock listing Interim Review
26th Sep 20187:00 amRNSIronveld supplies potential off-take partner
12th Jul 20185:02 pmRNSHolding(s) in Company
9th Jul 20187:00 amRNSDirector/PDMR Shareholding
23rd Apr 20187:00 amRNSBlocklisting Return
28th Mar 20187:00 amRNSInterim results for the 6 months ended 31 Dec 2017
28th Feb 20187:00 amRNSCompany Update
31st Jan 20189:00 amRNSHolding(s) in Company
23rd Jan 20185:18 pmRNSResult of AGM
23rd Jan 20189:45 amRNSTR-1: Notification of major holdings
19th Dec 20177:00 amRNSAppointment of Non-Executive Director
7th Dec 20177:00 amRNSFinal results for the year ended 30 June 2017
27th Nov 20177:00 amRNSPlacing to raise £1.765 million
30th Oct 201712:10 pmRNSHolding(s) in Company
23rd Oct 20177:00 amRNSBlocklisting Return
12th Oct 20177:00 amRNSCompany Update
4th Oct 201710:45 amRNSHolding(s) in Company
25th Jul 20179:07 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.